KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Receivables (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Receivables for 9 consecutive years, with $940.0 million as the latest value for Q4 2025.

  • Quarterly Receivables rose 6.09% to $940.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $940.0 million through Dec 2025, up 6.09% year-over-year, with the annual reading at $940.0 million for FY2025, 6.09% up from the prior year.
  • Receivables hit $940.0 million in Q4 2025 for Elanco Animal Health, down from $975.0 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $1.3 billion in Q1 2023 to a low of $886.0 million in Q4 2024.
  • Historically, Receivables has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2024.
  • Biggest five-year swings in Receivables: surged 90.34% in 2021 and later decreased 20.35% in 2024.
  • Year by year, Receivables stood at $1.0 billion in 2021, then fell by 2.53% to $1.0 billion in 2022, then increased by 0.8% to $1.0 billion in 2023, then dropped by 12.28% to $886.0 million in 2024, then grew by 6.09% to $940.0 million in 2025.
  • Business Quant data shows Receivables for ELAN at $940.0 million in Q4 2025, $975.0 million in Q3 2025, and $1.1 billion in Q2 2025.